A Bombesin-Shepherdin Radioconjugate Designed for Combined Extra- and Intracellular Targeting

Radiolabeled peptides which target tumor-specific membrane structures of cancer cells represent a promising class of targeted radiopharmaceuticals for the diagnosis and therapy of cancer. A potential drawback of a number of reported radiopeptides is the rapid washout of a substantial fraction of the...

Full description

Saved in:
Bibliographic Details
Main Authors: Christiane A. Fischer (Author), Sandra Vomstein (Author), Thomas L. Mindt (Author)
Format: Book
Published: MDPI AG, 2014-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_08a4dd019dc940b0922cc5cf4f448fa0
042 |a dc 
100 1 0 |a Christiane A. Fischer  |e author 
700 1 0 |a Sandra Vomstein  |e author 
700 1 0 |a Thomas L. Mindt  |e author 
245 0 0 |a A Bombesin-Shepherdin Radioconjugate Designed for Combined Extra- and Intracellular Targeting 
260 |b MDPI AG,   |c 2014-05-01T00:00:00Z. 
500 |a 1424-8247 
500 |a 10.3390/ph7060662 
520 |a Radiolabeled peptides which target tumor-specific membrane structures of cancer cells represent a promising class of targeted radiopharmaceuticals for the diagnosis and therapy of cancer. A potential drawback of a number of reported radiopeptides is the rapid washout of a substantial fraction of the initially delivered radioactivity from cancer cells and tumors. This renders the initial targeting effort in part futile and results in a lower imaging quality and efficacy of the radiotracer than achievable. We are investigating the combination of internalizing radiopeptides with molecular entities specific for an intracellular target. By enabling intracellular interactions of the radioconjugate, we aim at reducing/decelerating the externalization of radioactivity from cancer cells. Using the "click-to-chelate" approach, the 99mTc-tricarbonyl core as a reporter probe for single-photon emission computed tomography (SPECT) was combined with the binding sequence of bombesin for extracellular targeting of the gastrin-releasing peptide receptor (GRP-r) and peptidic inhibitors of the cytosolic heat shock 90 protein (Hsp90) for intracellular targeting. Receptor-specific uptake of the multifunctional radioconjugate could be confirmed, however, the cellular washout of radioactivity was not improved. We assume that either endosomal trapping or lysosomal degradation of the radioconjugate is accountable for these observations. 
546 |a EN 
690 |a multifunctional radioconjugates 
690 |a intra- and extracellular targeting 
690 |a tumor-targeting 
690 |a 99mTc-tricarbonyl 
690 |a bombesin 
690 |a shepherdin 
690 |a gastrin releasing peptide receptor 
690 |a Hsp90 
690 |a SPECT 
690 |a Medicine 
690 |a R 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceuticals, Vol 7, Iss 6, Pp 662-675 (2014) 
787 0 |n http://www.mdpi.com/1424-8247/7/6/662 
787 0 |n https://doaj.org/toc/1424-8247 
856 4 1 |u https://doaj.org/article/08a4dd019dc940b0922cc5cf4f448fa0  |z Connect to this object online.